Patents by Inventor Johanna Hansen

Johanna Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230348569
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Application
    Filed: June 29, 2023
    Publication date: November 2, 2023
    Inventors: Robert BABB, Alina BAUM, Gang CHEN, Cindy GERSON, Johanna HANSEN, Tammy HUANG, Christos KYRATSOUS, Wen-Yi LEE, Marine MALBEC, Andrew MURPHY, William OLSON, Neil STAHL, George D. YANCOPOULOS
  • Patent number: 11732030
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 22, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Publication number: 20230060095
    Abstract: The present invention provides isolated T cell receptors (TCRs) that specifically bind to an HLA-displayed cancer testis antigen preferentially expressed antigen in melanoma (FRAME) peptide, as well as therapeutic and diagnostic methods of using those isolated TCRs.
    Type: Application
    Filed: January 22, 2021
    Publication date: February 23, 2023
    Inventors: Natalie Bowerman, Johanna Hansen
  • Publication number: 20220356230
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Application
    Filed: March 19, 2021
    Publication date: November 10, 2022
    Inventors: Robert Babb, Alina BAUM, Gang CHEN, Cindy GERSON, Johanna HANSEN, Tammy HUANG, Christos KYRATSOUS, Wen-Yi LEE, Marine MALBEC, Andrew MURPHY, William OLSON, Neil STAHL, George D. YANCOPOULOS
  • Publication number: 20220330532
    Abstract: The present disclosure provides, among other things, genetically modified non-human animals whose germline genome comprises an engineered endogenous immunoglobulin ? light chain locus comprising a single rearranged human immunoglobulin ? light chain variable region operably linked to a non-human C? gene segment, where the single rearranged human immunoglobulin ? light chain variable region comprises a human V? gene segment and a human J? gene segment. All immunoglobulin ? light chains expressed by B cells of the genetically modified non-human animal include human immunoglobulin ? light chain variable domains expressed from the single rearranged human immunoglobulin ? light chain variable region or a somatically hypermutated version thereof. Such animals, tissues from such animals, and cells from such animals represent an effective platform for producing antibodies, e.g., bispecific antibodies.
    Type: Application
    Filed: June 4, 2020
    Publication date: October 20, 2022
    Inventors: John McWhirter, Johanna Hansen, Robert Babb, Chunguang Guo, Lynn Macdonald, Andrew J. Murphy
  • Publication number: 20220324939
    Abstract: The present invention provides isolated T cell receptors (TCRs) that specifically bind to an HLA-displayed cancer testis antigen Melanoma-Associated Antigen A4 (MAGE-A4) peptide, as well as therapeutic and diagnostic methods of using those isolated TCRs. The present invention provides T cell receptors (TCRs) that were generated against a MAGE-A4 peptide antigen in the context of MHC (HLA-A2). The unique TCR sequences identified have shown specific binding to the small peptide MAGE-A4 presented in the groove of an HLA molecule and exhibited activation of T cells in a reporter assay.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 13, 2022
    Inventors: Natalie Bowerman, Cagan Gurer, Johanna Hansen
  • Publication number: 20210403527
    Abstract: The present invention provides isolated T cell receptors (TCRs) that specifically bind to an HLA-displayed New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1) peptides, as well as therapeutic and diagnostic methods of using those isolated TCRs.
    Type: Application
    Filed: October 23, 2019
    Publication date: December 30, 2021
    Inventors: Robert Babb, Natalie Bowerman, Gang Chen, Cagan Gurer, Johanna Hansen, Wen-Yi Lee, Thomas Meagher, David Suh
  • Patent number: 10975139
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: April 13, 2021
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Patent number: 10954289
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: March 23, 2021
    Assignee: Regeneren Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Patent number: 10787501
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: September 29, 2020
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Patent number: 8101047
    Abstract: Ash composition measurements of calcium carbonate and gypsum in paper is accomplished with a dual X-ray sensor system with one X-ray source that is powered at about 5.9 KV and a second X-ray source that is powered at about 4.2 KV. Corresponding detectors measure radiation from the respective X-ray sources that is emitted from the paper. Data derived from the measurements yields the gypsum and crystal water content in the paper. The dual X-ray sensor system can be employed in conjunction with infrared total moisture measurements of paper products being manufactured on a papermaking making machine, which contain gypsum and calcium carbonate, in order to correct for the gypsum crystal water effect.
    Type: Grant
    Filed: September 16, 2009
    Date of Patent: January 24, 2012
    Assignee: Honeywell International Inc.
    Inventors: Unto Kulma, Jaakko Olavi Uusalo, Antti Paavola, Johanna Hansen, Gertjan Hofman
  • Publication number: 20100078139
    Abstract: Ash composition measurements of calcium carbonate and gypsum in paper is accomplished with a dual X-ray sensor system with one X-ray source that is powered at about 5.9 KV and a second X-ray source that is powered at about 4.2 KV. Corresponding detectors measure radiation from the respective X-ray sources that is emitted from the paper. Data derived from the measurements yields the gypsum and crystal water content in the paper. The dual X-ray sensor system can be employed in conjunction with infrared total moisture measurements of paper products being manufactured on a papermaking making machine, which contain gypsum and calcium carbonate, in order to correct for the gypsum crystal water effect.
    Type: Application
    Filed: September 16, 2009
    Publication date: April 1, 2010
    Applicant: Honeywell International Inc.
    Inventors: Unto Kulma, Jaakko Olavi Uusalo, Antti Paavola, Johanna Hansen, Gertjan Hofman